Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Emily Riddle, Nancy Munoz, Krista Clark, Nancy Collins, Anne Coltman, Lamia Nasrallah, Shinta Nishioka, Terese Scollard, Judy R Simon, Lisa Moloney
Malnutrition in older adults can decrease quality of life and increase risk for morbidities and mortality. Accurate and timely identification of malnutrition as well as subsequent implementation of effective interventions are essential to decrease poor outcomes associated with malnutrition in older adults. The Academy of Nutrition and Dietetics Evidence Analysis Center conducted a systematic review of the literature to develop an evidence-based practice guideline for the prevention and treatment of malnutrition in older adults (MiOA)...
April 5, 2024: Journal of the Academy of Nutrition and Dietetics
#2
JOURNAL ARTICLE
Emily Strouphauer, Carlos Valenzuela-Flores, Abu Minhajuddin, Holli Slater, David B Riddle, Caitlin M Pinciotti, Andrew G Guzick, John M Hettema, Silvina Tonarelli, Cesar A Soutullo, Joshua S Elmore, Kimberly Gushanas, Sarah Wakefield, Wayne K Goodman, Madhukar H Trivedi, Eric A Storch, Matti Cervin
BACKGROUND: Major depressive disorder (MDD) is common in youth and among the most frequent comorbid disorders in pediatric obsessive-compulsive disorder (OCD), but it is unclear whether the presence of OCD affects the symptom presentation of MDD in youth. METHODS: A sample of youth with OCD and MDD (n = 124) and a sample of youth with MDD but no OCD (n = 673) completed the Patient Health Questionnaire for Adolescents (PHQ-A). The overall and symptom-level presentation of MDD were examined using group comparisons and network analysis...
January 8, 2024: Journal of Affective Disorders
#3
Fares Bassil, Hannah J Brown, Shankar Pattabhiraman, Joe E Iwasyk, Chantal M Maghames, Emily S Meymand, Timothy O Cox, Dawn M Riddle, Bin Zhang, John Q Trojanowski, Virginia M-Y Lee
No abstract text is available yet for this article.
November 15, 2023: Neuron
#4
JOURNAL ARTICLE
Alexandra Touroutoglou, Yuta Katsumi, Michael Brickhouse, Alexander Zaitsev, Ryan Eckbo, Paul Aisen, Laurel Beckett, Jeffrey L Dage, Ani Eloyan, Tatiana Foroud, Bernardino Ghetti, Percy Griffin, Dustin Hammers, Clifford R Jack, Joel H Kramer, Leonardo Iaccarino, Renaud La Joie, Nidhi S Mundada, Robert Koeppe, Walter A Kukull, Melissa E Murray, Kelly Nudelman, Angelina J Polsinelli, Malia Rumbaugh, David N Soleimani-Meigooni, Arthur Toga, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph C Masdeu, Mario F Mendez, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon Sha, R Scott Turner, Thomas S Wingo, David A Wolk, Kyle Womack, Maria C Carrillo, Gil D Rabinovici, Liana G Apostolova, Bradford C Dickerson
INTRODUCTION: Magnetic resonance imaging (MRI) research has advanced our understanding of neurodegeneration in sporadic early-onset Alzheimer's disease (EOAD) but studies include small samples, mostly amnestic EOAD, and have not focused on developing an MRI biomarker. METHODS: We analyzed MRI scans to define the sporadic EOAD-signature atrophy in a small sample (n = 25) of Massachusetts General Hospital (MGH) EOAD patients, investigated its reproducibility in the large longitudinal early-onset Alzheimer's disease study (LEADS) sample (n = 211), and investigated the relationship of the magnitude of atrophy with cognitive impairment...
October 18, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#5
REVIEW
Kelly N H Nudelman, Trever Jackson, Malia Rumbaugh, Ani Eloyan, Marco Abreu, Jeffrey L Dage, Casey Snoddy, Kelley M Faber, Tatiana Foroud, Dustin B Hammers, Alexander Taurone, Maryanne Thangarajah, Paul Aisen, Laurel Beckett, Joel Kramer, Robert Koeppe, Walter A Kukull, Melissa E Murray, Arthur W Toga, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph C Masdeu, Mario Mendez, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J Sha, R Scott Turner, Thomas S Wingo, David A Wolk, Maria C Carrillo, Bradford C Dickerson, Gil D Rabinovici, Liana G Apostolova
INTRODUCTION: One goal of the Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is to investigate the genetic etiology of early onset (40-64 years) cognitive impairment. Toward this goal, LEADS participants are screened for known pathogenic variants. METHODS: LEADS amyloid-positive early-onset Alzheimer's disease (EOAD) or negative early-onset non-AD (EOnonAD) cases were whole exome sequenced (N = 299). Pathogenic variant frequency in APP, PSEN1, PSEN2, GRN, MAPT, and C9ORF72 was assessed for EOAD and EOnonAD...
October 6, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#6
JOURNAL ARTICLE
Hanna Cho, Nidhi S Mundada, Liana G Apostolova, Maria C Carrillo, Ranjani Shankar, Alinda N Amuiri, Ehud Zeltzer, Charles C Windon, David N Soleimani-Meigooni, Jeremy A Tanner, Courtney Lawhn Heath, Orit H Lesman-Segev, Paul Aisen, Ani Eloyan, Hye Sun Lee, Dustin B Hammers, Kala Kirby, Jeffrey L Dage, Anne Fagan, Tatiana Foroud, Lea T Grinberg, Clifford R Jack, Joel Kramer, Walter A Kukull, Melissa E Murray, Kelly Nudelman, Arthur Toga, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph Masdeu, Mario Mendez, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily J Rogalski, Stephen Salloway, Sharon Sha, Raymond Scott Turner, Thomas S Wingo, David A Wolk, Robert Koeppe, Leonardo Iaccarino, Bradford C Dickerson, Renaud La Joie, Gil D Rabinovici
INTRODUCTION: We aimed to describe baseline amyloid-beta (Aβ) and tau-positron emission tomograrphy (PET) from Longitudinal Early-onset Alzheimer's Disease Study (LEADS), a prospective multi-site observational study of sporadic early-onset Alzheimer's disease (EOAD). METHODS: We analyzed baseline [18F]Florbetaben (Aβ) and [18F]Flortaucipir (tau)-PET from cognitively impaired participants with a clinical diagnosis of mild cognitive impairment (MCI) or AD dementia aged < 65 years...
September 10, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#7
JOURNAL ARTICLE
Justin Bushnell, Dustin B Hammers, Paul Aisen, Jeffrey L Dage, Ani Eloyan, Tatiana Foroud, Lea T Grinberg, Leonardo Iaccarino, Clifford R Jack, Kala Kirby, Joel Kramer, Robert Koeppe, Walter A Kukull, Renaud La Joie, Nidhi S Mundada, Melissa E Murray, Kelly Nudelman, Malia Rumbaugh, David N Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph Masdeu, Mario Mendez, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon Sha, Raymond S Turner, Thomas S Wingo, David A Wolk, Maria C Carrillo, Bradford C Dickerson, Gil D Rabinovici, Liana G Apostolova, David G Clark
INTRODUCTION: The Rey Auditory Verbal Learning Test (RAVLT) is a useful neuropsychological test for describing episodic memory impairment in dementia. However, there is limited research on its utility in early-onset Alzheimer's disease (EOAD). We assess the influence of amyloid and diagnostic syndrome on several memory scores in EOAD. METHODS: We transcribed RAVLT recordings from 303 subjects in the Longitudinal Early-Onset Alzheimer's Disease Study. Subjects were grouped by amyloid status and syndrome...
August 31, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#8
JOURNAL ARTICLE
Sára Nemes, Paige E Logan, Mohit K Manchella, Nidhi S Mundada, Renaud La Joie, Angelina J Polsinelli, Dustin B Hammers, Robert A Koeppe, Tatiana M Foroud, Kelly N Nudelman, Ani Eloyan, Leonardo Iaccarino, Valérie Dorsant-Ardón, Alexander Taurone, Maryanne Thangarajah, Jeffery L Dage, Paul Aisen, Lea T Grinberg, Clifford R Jack, Joel Kramer, Walter A Kukull, Melissa E Murray, Malia Rumbaugh, David N Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph Masdeu, Mario F Mendez, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J Sha, Raymond S Turner, Thomas S Wingo, Kyle B Womack, David A Wolk, Gil D Rabinovici, Maria C Carrillo, Bradford C Dickerson, Liana G Apostolova
INTRODUCTION: We used sex and apolipoprotein E ε4 (APOE ε4) carrier status as predictors of pathologic burden in early-onset Alzheimer's disease (EOAD). METHODS: We included baseline data from 77 cognitively normal (CN), 230 EOAD, and 70 EO non-Alzheimer's disease (EOnonAD) participants from the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS). We stratified each diagnostic group by males and females, then further subdivided each sex by APOE ε4 carrier status and compared imaging biomarkers in each stratification...
July 26, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#9
JOURNAL ARTICLE
Jeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, Dustin B Hammers, Anne M Fagan, Julia D Gray, Suzanne E Schindler, Casey Snoddy, Kelly N H Nudelman, Kelley M Faber, Tatiana Foroud, Paul Aisen, Percy Griffin, Lea T Grinberg, Leonardo Iaccarino, Kala Kirby, Joel Kramer, Robert Koeppe, Walter A Kukull, Renaud La Joie, Nidhi S Mundada, Melissa E Murray, Malia Rumbaugh, David N Soleimani-Meigooni, Arthur W Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Laurel A Beckett, Gregory S Day, Neill R Graff-Radford, Ranjan Duara, Lawrence S Honig, David T Jones, Joseph C Masdeu, Mario F Mendez, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J Sha, Raymond S Turner, Thomas S Wingo, David A Wolk, Kyle B Womack, Maria C Carrillo, Bradford C Dickerson, Gil D Rabinovici, Liana G Apostolova
INTRODUCTION: One goal of the Longitudinal Early Onset Alzheimer's Disease Study (LEADS) is to define the fluid biomarker characteristics of early-onset Alzheimer's disease (EOAD). METHODS: Cerebrospinal fluid (CSF) concentrations of Aβ1-40, Aβ1-42, total tau (tTau), pTau181, VILIP-1, SNAP-25, neurogranin (Ng), neurofilament light chain (NfL), and YKL-40 were measured by immunoassay in 165 LEADS participants. The associations of biomarker concentrations with diagnostic group and standard cognitive tests were evaluated...
July 25, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#10
JOURNAL ARTICLE
Devyn R Riddle, Emily K Presseller, Adrienne S Juarascio
OBJECTIVE: Emotion dysregulation (i.e., a multi-component term comprising nonacceptance of emotional responses, difficulty engaging in goal-directed behaviour, impulse control difficulties, lack of emotional awareness, limited access to emotion regulation strategies, and lack of emotional clarity) is a well-established transdiagnostic risk and maintenance factor for eating disorders. To date, there is limited information on how varying scores on subdomains of emotion dysregulation may yield distinct profiles in individuals with binge-spectrum eating disorders (B-EDs), and how these emotion dysregulation profiles may inform resultant symptomatology...
July 3, 2023: European Eating Disorders Review: the Journal of the Eating Disorders Association
#11
JOURNAL ARTICLE
Katherine Adams, John J Riddles, Elizabeth A K Rowley, Shaun J Grannis, Manjusha Gaglani, Bruce Fireman, Emily Hartmann, Allison L Naleway, Edward Stenehjem, Alexandria Hughes, Alexandra F Dalton, Karthik Natarajan, Kristin Dascomb, Chandni Raiyani, Stephanie A Irving, Chantel Sloan-Aagard, Anupam B Kharbanda, Malini B DeSilva, Brian E Dixon, Toan C Ong, Jean Keller, Monica Dickerson, Nancy Grisel, Kempapura Murthy, Juan Nanez, William F Fadel, Sarah W Ball, Palak Patel, Julie Arndorfer, Mufaddal Mamawala, Nimish R Valvi, Margaret M Dunne, Eric P Griggs, Peter J Embi, Mark G Thompson, Ruth Link-Gelles, Mark W Tenforde
BACKGROUND: Understanding the usefulness of additional COVID-19 vaccine doses-particularly given varying disease incidence-is needed to support public health policy. We characterize the benefits of COVID-19 booster doses using number needed to vaccinate (NNV) to prevent one COVID-19-associated hospitalization or emergency department encounter. METHODS: We conducted a retrospective cohort study of immunocompetent adults at five health systems in four U.S. states during SARS-CoV-2 Omicron BA...
July 2023: Lancet Reg Health Am
#12
JOURNAL ARTICLE
Brooke L Reidy, Emily J Riddle, Scott W Powers, Shalonda K Slater, Joanne Kacperski, Marielle Kabbouche, James L Peugh, Andrew D Hershey
BACKGROUND: Youth with continuous (always present) headache are vastly understudied; much remains to be understood regarding treatment response in this population. OBJECTIVE: To describe and explore biopsychosocial factors related to initial clinical outcomes among treatment-seeking youth with continuous headache. METHODS: This retrospective cohort study extracted data of 782 pediatric patients (i.e., aged <18 years) with continuous headache from a large clinical repository...
June 14, 2023: Headache
#13
JOURNAL ARTICLE
Angelina J Polsinelli, Ryan J Wonderlin, Dustin B Hammers, Alex Pena Garcia, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Laurel Beckett, Sujuan Gao, Sophia Wang, Kala Kirby, Paige E Logan, Paul Aisen, Jeffrey L Dage, Tatiana Foroud, Percy Griffin, Leonardo Iaccarino, Joel H Kramer, Robert Koeppe, Walter A Kukull, Renaud La Joie, Nidhi S Mundada, Melissa E Murray, Kelly Nudelman, David N Soleimani-Meigooni, Malia Rumbaugh, Arthur W Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph Masdeu, Mario F Mendez, Kyle Womack, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon J Sha, Raymond S Turner, Thomas S Wingo, David A Wolk, Maria C Carrillo, Bradford C Dickerson, Gil D Rabinovici, Liana G Apostolova
INTRODUCTION: We examined neuropsychiatric symptoms (NPS) and psychotropic medication use in a large sample of individuals with early-onset Alzheimer's disease (EOAD; onset 40-64 years) at the midway point of data collection for the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). METHODS: Baseline NPS (Neuropsychiatric Inventory - Questionnaire; Geriatric Depression Scale) and psychotropic medication use from 282 participants enrolled in LEADS were compared across diagnostic groups - amyloid-positive EOAD (n = 212) and amyloid negative early-onset non-Alzheimer's disease (EOnonAD; n = 70)...
June 9, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#14
JOURNAL ARTICLE
Dustin B Hammers, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Laurel Beckett, Sujuan Gao, Kala Kirby, Paul Aisen, Jeffrey L Dage, Tatiana Foroud, Percy Griffin, Lea T Grinberg, Clifford R Jack, Joel Kramer, Robert Koeppe, Walter A Kukull, Nidhi S Mundada, Renaud La Joie, David N Soleimani-Meigooni, Leonardo Iaccarino, Melissa E Murray, Kelly Nudelman, Angelina J Polsinelli, Malia Rumbaugh, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph Masdeu, Mario F Mendez, Kyle Womack, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon J Sha, Raymond Scott Turner, Thomas S Wingo, David A Wolk, Maria C Carrillo, Bradford C Dickerson, Gil D Rabinovici, Liana G Apostolova
OBJECTIVE: The Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) seeks to provide comprehensive understanding of early-onset Alzheimer's disease (EOAD; onset <65 years), with the current study profiling baseline clinical, cognitive, biomarker, and genetic characteristics of the cohort nearing the data-collection mid-point. METHODS: Data from 371 LEADS participants were compared based on diagnostic group classification (cognitively normal [n = 89], amyloid-positive EOAD [n = 212], and amyloid-negative early-onset non-Alzheimer's disease [EOnonAD; n = 70])...
May 31, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#15
JOURNAL ARTICLE
Dustin B Hammers, Sára Nemes, Taylor Diedrich, Ani Eloyan, Kala Kirby, Paul Aisen, Joel Kramer, Kelly Nudelman, Tatiana Foroud, Malia Rumbaugh, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph C Masdeu, Mario F Mendez, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Steve Salloway, Sharon J Sha, Raymond Scott Turner, Sandra Weintraub, Thomas S Wingo, David A Wolk, Bonnie Wong, Maria C Carrillo, Bradford C Dickerson, Gil D Rabinovici, Liana G Apostolova
OBJECTIVE: Investigation of learning slopes in early-onset dementias has been limited. The current study aimed to highlight the sensitivity of learning slopes to discriminate disease severity in cognitively normal participants and those diagnosed with early-onset dementia with and without β-amyloid positivity METHOD: Data from 310 participants in the Longitudinal Early-Onset Alzheimer's Disease Study (aged 41 to 65) were used to calculate learning slope metrics. Learning slopes among diagnostic groups were compared, and the relationships of slopes with standard memory measures were determined RESULTS: Worse learning slopes were associated with more severe disease states, even after controlling for demographics, total learning, and cognitive severity...
May 27, 2023: Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#16
JOURNAL ARTICLE
Catherine H Bozio, Kristen A Butterfield, Melissa Briggs Hagen, Shaun Grannis, Paul Drawz, Emily Hartmann, Toan C Ong, Bruce Fireman, Karthik Natarajan, Kristin Dascomb, Manjusha Gaglani, Malini B DeSilva, Duck-Hye Yang, Claire M Midgley, Brian E Dixon, Allison L Naleway, Nancy Grisel, I-Chia Liao, Sarah E Reese, William F Fadel, Stephanie A Irving, Ned Lewis, Julie Arndorfer, Kempapura Murthy, John Riddles, Nimish R Valvi, Mufaddal Mamawala, Peter J Embi, Mark G Thompson, Edward Stenehjem
BACKGROUND: Data assessing protection conferred from COVID-19 mRNA vaccination and/or prior SARS-CoV-2 infection during Delta and Omicron predominance periods in the U.S. are limited. METHODS: This cohort study included persons ≥18 years who had ≥1 healthcare encounter across four health systems and had been tested for SARS-CoV-2 before August 26, 2021. COVID-19 mRNA vaccination and prior SARS-CoV-2 infection defined the exposure. Cox regression estimated hazard ratios (HRs) for the Delta and Omicron periods; protection was calculated as (1-HR)x100%...
February 18, 2023: Journal of Infectious Diseases
#17
EDITORIAL
Emily J Riddle
No abstract text is available yet for this article.
January 2023: Headache
#18
JOURNAL ARTICLE
Jennifer L Bueche, Jennifer M K Jensen, Kelly Martin, Emily Riddle, Kim S Stote
The COVID-19 pandemic necessitated the use of distance education, which sparked a technological transformation that was long overdue in higher education. The purpose of this narrative review is two-fold: 1) to summarize the state of knowledge regarding distance education in nutrition and dietetics education over the last 30 years to inform recommendations for future education/research and implications for practice and 2) to determine the impact that distance education has had on the knowledge, skills, and attitudes of both nutrition and dietetic educators and their students...
November 15, 2022: Journal of the Academy of Nutrition and Dietetics
#19
JOURNAL ARTICLE
Naomi Dirckx, Qian Zhang, Emily Y Chu, Robert J Tower, Zhu Li, Shenghao Guo, Shichen Yuan, Pratik A Khare, Cissy Zhang, Angela Verardo, Lucy O Alejandro, Angelina Park, Marie-Claude Faugere, Stephen L Helfand, Martha J Somerman, Ryan C Riddle, Rafael de Cabo, Anne Le, Klaus Schmidt-Rohr, Thomas L Clemens
Citrate is a critical metabolic substrate and key regulator of energy metabolism in mammalian cells. It has been known for decades that the skeleton contains most (>85%) of the body's citrate, but the question of why and how this metabolite should be partitioned in bone has received singularly little attention. Here, we show that osteoblasts use a specialized metabolic pathway to regulate uptake, endogenous production, and the deposition of citrate into bone. Osteoblasts express high levels of the membranous Na+ -dependent citrate transporter solute carrier family 13 member 5 ( Slc13a5 ) gene...
November 8, 2022: Proceedings of the National Academy of Sciences of the United States of America
#20
JOURNAL ARTICLE
Amit Bahl, William Wilson, Jessica Ball, Emily Renninson, Sidharth Dubey, Alicia Bravo, Emily Foulstone, Saiqa Spensley, Rebecca Bowen, Janine Mansi, Simon Waters, Pippa Riddle, Duncan Wheatley, Peter Stephens, Pavel Bezecny, Srinivasan Madhusudan, Mark Verrill, Jeremy Braybrooke, Charles Comins, Vivek Mohan, Abigail Gee, Hannah Kirk, Alison Markham, Heidi Evans, Eve Watson, Mark Callaway, Sylvia Pearson, Allan Hackshaw, Mark Churn
BACKGROUND: Paclitaxel is commonly used as first-line chemotherapy for HER2-negative metastatic breast cancer (MBC) patients. However, with response rates of 21.5-53.7% and significant risk of peripheral neuropathy, there is need for better chemotherapy. PATIENTS AND METHODS: This open-label phase II/III trial randomised HER2-negative MBC patients 1:1 to either 6 cycles of three-weekly cabazitaxel (25 mg/m2 ), or, weekly paclitaxel (80 mg/m2 ) over 18 weeks. The primary endpoint was progression free survival (PFS)...
September 24, 2022: Breast: Official Journal of the European Society of Mastology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
